R&D

Deep Dive: Research and Development 2024

In this edition of Deep Dive, delve into the revolutionary world of genetic editing as we trace the development of CRISPR, discover why Alexion’s Soraya Bekkali believes now it the time to champion

News

Pfizer’s new cancer unit sees eight new blockbusters by 2030

Fresh from the $43 billion acquisition of antibody-drug conjugate (ADC) specialist Seagen, Pfizer has laid out plans for its dedicated oncology division in front of invest

R&D

Abstract laptop with coloured DNA molecule

Understanding the impact of AI on the advancement of gene th...

The biopharmaceutical landscape stands at the cusp of a transformative era, with artificial intelligence (AI) leading the charge.

R&D

Why Scotland is well-positioned to lead in advanced therapie...

The global health burden of complex diseases such as severe lung, liver, and vascular disease is huge, and growing by the second.

News

Update: Orion buys stake in LegoChem as biotech push goes on

Food group Orion Group has taken a 25% in South Korean biotech LegoChem Bioscience, becoming its largest shareholder, as part of a push into the biotech sector.

Market Access